No Photo Available

Last Update

2016-06-29T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Mark McKeage?

Dr. Mark J. McKeage

Professor, Medical Oncologist and Co-Director

University of Auckland

HQ Phone: +64 9-470 1000

Email: m***@***.nz

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University of Auckland

22 Princes Street Private Bag 92019

Auckland, Auckland 1000

New Zealand

Find other employees at this company (6,524)

Background Information

Employment History

Consultant

Novartis AG

Researcher

Oncologist and Auckland University

Lead Investigator Associate Professor

Waikato Hospital

Affiliations

Scientific Advisor
ClinicaSpace Company

Education

M.D.

MBChB MMedSc PhD

University of Auckland

Web References (53 Total References)


Associate Investigators | Maurice Wilkins Centre

www.mauricewilkinscentre.org [cached]

Associate Professor Mark McKeage

Department of Pharmacology - The University of Auckland


"Through the current Phase 1b study ...

www.digitalproducer.com [cached]

"Through the current Phase 1b study in NSCLC and prior Phase 1 trials of demcizumab we have learned much about its safety and anti-tumor properties," said Mark McKeage, MBChB, MMedSc, Ph.D., FRACP, University of Auckland.

...
Presenting author: Mark McKeage, MBChB, MMedSc, Ph.D., FRACP, University of Auckland


Editorial Team - Journal of Thoracic Disease

www.jthoracdis.com [cached]

Mark J. McKeage, MD Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, New Zealand


Local cancer drug approved for first clinical trial in United States and New Zealand | Maurice Wilkins Centre

www.mauricewilkinscentre.org [cached]

For the first time we will be screening patients for the genetic mutation that causes drug resistance and then enrolling them in a trial of a New Zealand drug designed to target that mutation," says ACSRC Co-Director, Associate Professor Mark McKeage, the Clinical Oncologist leading the Auckland City Hospital trial, referring to the phase II part of the phase I/II trial.

...
Drs Jeff Smaill and Adam Patterson, Professor Bill Denny and Associate Professor Mark McKeage are all Maurice Wilkins Centre investigators.


For the first time we will ...

www.scoop.co.nz [cached]

For the first time we will be screening patients for the genetic mutation that causes drug resistance and then enrolling them in a trial of a New Zealand drug designed to target that mutation, says ACSRC Co-Director, Associate Professor Mark McKeage, the Clinical Oncologist leading the Auckland City Hospital trial, referring to the phase II part of the phase I/II trial.

...
Drs Jeff Smaill and Adam Patterson, Professor Bill Denny and Associate Professor Mark McKeage are all Maurice Wilkins Centre investigators.

Similar Profiles

Other People with this Name

Other people with the name McKeage

Victoria McKeage
Magna International Inc

Susan McKeage
Nova Scotia Museum

Judy McKeage
LB Steel LLC

Robert McKeage
American Water

James McKeage
Hertz Equipment Rental Corporation

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory